December
Financial Update for the quarter ended December 31, 2015September
Financial Update for the quarter ended September 30, 2015August
Unaudited Financial Results for the Quarter ended June 30, 2015Claris Lifesciences Limited receives Prior Approval Supplement for Furosemide Injection in US
Income Tax Authorities - Search / Survey
July
Pharm Exec recognises Mr. Arjun Handa, Vice Chairman & MD in 'Emerging Pharma Leaders 2015'May
The Economic Times Ascent features article of Claris' President - HRM & Corp. Communication
Audited Financial results for the quarter and financial year (Fifteen Months) ended 31st March 2015
April
Claris Lifesciences Limited receives supplemental ANDA approval for Fluconazole injection in 50ml PVC BagsClaris Lifesciences Limited announces settlement of litigations and license agreement for its generic DIPRIVAN in USA
March
Ind-Ra affirms ‘IND A’ rating to ClarisFebruary
Unaudited Financial Results for the Quarter ended 31st December, 2014January
Half Marathon Amdavad, powered by Claris, concludes on a high note
